A carregar...
Antibody-drug conjugates—an emerging class of cancer treatment
Antibody-drug conjugates (ADCs) are an emerging novel class of anticancer treatment agents that combines the selectivity of targeted treatment with the cytotoxic potency of chemotherapy drugs. New linker technology associated with novel highly potent cytotoxic payloads has permitted the development...
Na minha lista:
| Publicado no: | Br J Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4815767/ https://ncbi.nlm.nih.gov/pubmed/26742008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.435 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|